Bristol-Myers Squibb  PERFORMANCE GRAPH  The following performance graph compares the performance of Bristol-Myers Squibb for the periods indicated with the performance  of the Standard & Poor’s 500 Stock Index (S&P 500) and the average performance of a group consisting of our peer corporations on a  line-of-business basis. The corporations making up our Peer Group are Abbott Laboratories, Amgen Inc., AstraZeneca PLC, Biogen  Idec Inc., Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis AG,  Pfizer, Inc., Roche Holding Ltd., and Sanofi.  Total return indices reflect reinvested dividends and are weighted using beginning-period market capitalization for each of the  reported time periods. $0 $50 $100 $150 $200 2007 2008 2009 2010 2011 2012 Comparison of Cumulative Five Year Total Return  Bristol-Myers Squibb S&P 500 Index Peer Group Assumes $100 invested on 12/31/07 in Bristol-Myers Squibb common stock, S&P 500 Index, and Peer Group. Values are as of  December 31 of specified year assuming dividends are reinvested.  12/31/07 12/31/08 12/31/09 12/31/10 12/31/11 12/31/12  Bristol-Myers Squibb   $ 100   $  94   $ 108   $ 118   $ 164   $ 158  S&P 500 Index   $ 100   $  63   $  80   $  92   $  94   $ 109  Peer Group   $ 100   $  86   $  97   $  96   $ 111   $ 132  78